{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T22:25:14Z","timestamp":1767651914939},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1038\/ncprheum0252","type":"journal-article","created":{"date-parts":[[2006,8,4]],"date-time":"2006-08-04T22:20:28Z","timestamp":1154730028000},"page":"452-456","source":"Crossref","is-referenced-by-count":37,"title":["Hypertrophic osteoarthropathy pathogenesis: a case highlighting the potential role for cyclo-oxygenase-2-derived prostaglandin E2"],"prefix":"10.1038","volume":"2","author":[{"given":"Kevin R","family":"Kozak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ginger L","family":"Milne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason D","family":"Morrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry P","family":"Cuiffo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BFncprheum0252_CR1","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.ab.2004.08.019","volume":"334","author":"LJ Murphey","year":"2004","unstructured":"Murphey LJ  et al. (2004) Quantification of the major urinary metabolite of PGE2 by a liquid chromatographic\/mass spectrometric assay: determination of cyclooxygenase-specific PGE2 synthesis in healthy humans and those with lung cancer. Anal Biochem 334: 266\u2013275","journal-title":"Anal Biochem"},{"key":"BFncprheum0252_CR2","doi-asserted-by":"publisher","first-page":"6087","DOI":"10.1158\/1078-0432.CCR-05-0733","volume":"11","author":"ND Gross","year":"2005","unstructured":"Gross ND  et al. (2005) Levels of prostaglandin E metabolite, the major urinary metabolite of prostaglandin E2, are increased in smokers. Clin Cancer Res 11: 6087\u20136093","journal-title":"Clin Cancer Res"},{"key":"BFncprheum0252_CR3","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/00002281-199701000-00016","volume":"9","author":"M Martinez-Lavin","year":"1997","unstructured":"Martinez-Lavin M (1997) Hypertrophic osteoarthropathy. Curr Opin Rheumatol 9: 83\u201386","journal-title":"Curr Opin Rheumatol"},{"key":"BFncprheum0252_CR4","first-page":"8.46.1","volume-title":"Rheumatology","author":"M Martinez-Lavin","year":"1998","unstructured":"Martinez-Lavin M (1998) Hypertrophic osteoarthropathy. In Rheumatology, 8.46.1\u20138.46.4 (Eds Klippel JH and Dieppe PA) London: Mosby"},{"key":"BFncprheum0252_CR5","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0049-0172(99)80037-7","volume":"29","author":"JE Naschitz","year":"1999","unstructured":"Naschitz JE  et al. (1999) Rheumatic syndromes: clues to occult neoplasia. Semin Arthritis Rheum 29: 43\u201355","journal-title":"Semin Arthritis Rheum"},{"key":"BFncprheum0252_CR6","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.ejim.2004.04.017","volume":"15","author":"X Vandemergel","year":"2004","unstructured":"Vandemergel X  et al. (2004) Periostitis and hypertrophic osteoarthropathy: etiologies and bone scan patterns in 115 cases. Eur J Intern Med 15: 375\u2013380","journal-title":"Eur J Intern Med"},{"key":"BFncprheum0252_CR7","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/S0140-6736(87)91132-9","volume":"2","author":"CJ Dickinson","year":"1987","unstructured":"Dickinson CJ and Martin JF (1987) Megakaryocytes and platelet clumps as the cause of finger clubbing. Lancet 2: 1434\u20131435","journal-title":"Lancet"},{"key":"BFncprheum0252_CR8","first-page":"614","volume":"31","author":"F Olan","year":"2004","unstructured":"Olan F  et al. (2004) Circulating vascular endothelial growth factor concentrations in a case of pulmonary hypertrophic osteoarthropathy. Correlation with disease activity. J Rheumatol 31: 614\u2013616","journal-title":"J Rheumatol"},{"key":"BFncprheum0252_CR9","first-page":"57","volume":"18","author":"LH Silveira","year":"2000","unstructured":"Silveira LH  et al. (2000) Vascular endothelial growth factor and hypertrophic osteoarthropathy. Clin Exp Rheumatol 18: 57\u201362","journal-title":"Clin Exp Rheumatol"},{"key":"BFncprheum0252_CR10","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1093\/rheumatology\/keh720","volume":"44","author":"AA Maroto","year":"2005","unstructured":"Maroto AA  et al. (2005) Painful hypertrophic osteoarthropathy successfully treated with octreotide. The pathogenetic role of vascular endothelial growth factor (VEGF). Rheumatology 44: 1326\u20131327","journal-title":"Rheumatology"},{"key":"BFncprheum0252_CR11","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/225600a0","volume":"225","author":"PJ Piper","year":"1970","unstructured":"Piper PJ  et al. (1970) Inactivation of prostaglandins by the lungs. Nature 225: 600\u2013604","journal-title":"Nature"},{"key":"BFncprheum0252_CR12","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1056\/NEJM197512182932502","volume":"293","author":"HW Seyberth","year":"1975","unstructured":"Seyberth HW  et al. (1975) Prostaglandins as mediators of hypercalcemia associated with certain types of cancer. New Engl J Med 293: 1278\u20131283","journal-title":"New Engl J Med"},{"key":"BFncprheum0252_CR13","first-page":"834","volume":"13","author":"M Martinez-Lavin","year":"1986","unstructured":"Martinez-Lavin M and Castillejos G (1986) Reply to: Ferritin and prostaglandins in hypertrophic osteoarthropathy. J Rheumatol 13: 834\u2013836","journal-title":"J Rheumatol"},{"key":"BFncprheum0252_CR14","first-page":"639","volume":"117","author":"RJ Lemen","year":"1978","unstructured":"Lemen RJ  et al. (1978) Relationships among digital clubbing, disease severity, and serum prostaglandins F2\u03b1 and E concentrations in cystic fibrosis patients. Am Rev Respir Dis 117: 639\u2013646","journal-title":"Am Rev Respir Dis"},{"key":"BFncprheum0252_CR15","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1172\/JCI107987","volume":"55","author":"JC Frolich","year":"1975","unstructured":"Frolich JC  et al. (1975) Urinary prostaglandins. Identification and origin. J Clin Invest 55: 763\u2013770","journal-title":"J Clin Invest"},{"key":"BFncprheum0252_CR16","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1097\/00001813-200110000-00004","volume":"12","author":"T Suzuma","year":"2001","unstructured":"Suzuma T  et al. (2001) Pamidronate-induced remission of pain associated with hypertrophic pulmonary osteoarthropathy in chemoendocrine therapy-refractory inoperable metastatic breast carcinoma. Anticancer Drugs 12: 731\u2013734","journal-title":"Anticancer Drugs"},{"key":"BFncprheum0252_CR17","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1378\/chest.121.4.1363","volume":"121","author":"LA Garske","year":"2002","unstructured":"Garske LA and Bell SC (2002) Pamidronate results in symptom control of hypertrophic pulmonary osteoarthropathy in cystic fibrosis. Chest 121: 1363\u20131364","journal-title":"Chest"},{"key":"BFncprheum0252_CR18","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/s10067-004-0941-4","volume":"23","author":"H Amital","year":"2004","unstructured":"Amital H  et al. (2004) Hypertrophic pulmonary osteoarthropathy: control of pain and symptoms with pamidronate. Clin Rheumatol 23: 330\u2013332","journal-title":"Clin Rheumatol"},{"key":"BFncprheum0252_CR19","first-page":"2418","volume":"27","author":"MH Guyot-Drouot","year":"2000","unstructured":"Guyot-Drouot MH  et al. (2000) Rheumatologic manifestations of pachydermoperiostosis and preliminary experience with bisphosphonates. J Rhemumatol 27: 2418\u20132423","journal-title":"J Rhemumatol"},{"key":"BFncprheum0252_CR20","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1136\/thx.52.3.298","volume":"52","author":"SA Johnson","year":"1997","unstructured":"Johnson SA  et al. (1997) Treatment of resistant pain in hypertrophic pulmonary osteoarthropathy with subcutaneous octreotide. Thorax 52: 298\u2013299","journal-title":"Thorax"}],"container-title":["Nature Clinical Practice Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncprheum0252.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncprheum0252","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/ncprheum0252","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/ncprheum0252.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T20:59:33Z","timestamp":1684443573000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncprheum0252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["BFncprheum0252"],"URL":"https:\/\/doi.org\/10.1038\/ncprheum0252","relation":{},"ISSN":["1745-8382","1745-8390"],"issn-type":[{"value":"1745-8382","type":"print"},{"value":"1745-8390","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,8]]}}}